Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect.
Wenkai ChenWenping LinNaichun YuLinlin ZhangZuoxing WuYongjie ChenZongguang LiFengqing GongNa LiXiaohui ChenXu HeYue WuXiangchen ZengYuting YuehRen XuGuangrong JiPublished in: International journal of nanomedicine (2022)
The potent Drp1 agonist, rifampicin, induced OS apoptosis and exosome loading, improving OS targeting and mouse survival rates. EXO-RIF is a promising strategy for the treatment of diverse malignancies.